[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:opioid-withdrawal":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":46,"states":47},"Opioid withdrawal",6,[7,14,21,27,34,40],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT07079826","Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder",[],"RECRUITING","2026-08-26T02:15:17.167444Z","2026-05-05T02:43:29.161599Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT06538558","Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder",[18],"Phase 1","2026-08-26T02:15:58.452248Z","2026-05-05T02:43:28.986782Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":25,"content_modified":26},"NCT05555485","Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain",[],"2026-08-26T02:18:14.396999Z","2026-05-05T02:43:27.090086Z",{"nct_id":28,"title":29,"phases":30,"status":11,"updated_at":32,"content_modified":33},"NCT05511909","Evaluating Buspirone to Treat Opioid Withdrawal",[31],"Phase 2","2026-08-26T02:17:16.126291Z","2026-05-13T02:55:06.352698Z",{"nct_id":35,"title":36,"phases":37,"status":11,"updated_at":38,"content_modified":39},"NCT06487533","Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder",[],"2026-08-26T02:18:38.077159Z","2026-05-13T02:55:06.494529Z",{"nct_id":41,"title":42,"phases":43,"status":11,"updated_at":44,"content_modified":45},"NCT05027919","Assessing a Clinically-meaningful Opioid Withdrawal Phenotype",[31],"2026-08-26T02:15:10.362237Z","2026-05-05T02:43:29.507441Z",[],[]]